440 related articles for article (PubMed ID: 30610438)
1. Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects.
Feng H; Wang C; He W; Wu X; Li S; Zeng Z; Wei M; He B
Metab Brain Dis; 2019 Apr; 34(2):583-591. PubMed ID: 30610438
[TBL] [Abstract][Full Text] [Related]
2. FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP/PS1 transgenic mice via cAMP/PKA/CREB signaling and anti-inflammatory effects.
Guo H; Cheng Y; Wang C; Wu J; Zou Z; Niu B; Yu H; Wang H; Xu J
Neuropharmacology; 2017 Apr; 116():260-269. PubMed ID: 28065587
[TBL] [Abstract][Full Text] [Related]
3. The Phosphodiesterase-4 Inhibitor Roflumilast, a Potential Treatment for the Comorbidity of Memory Loss and Depression in Alzheimer's Disease: A Preclinical Study in APP/PS1 Transgenic Mice.
Wang H; Zhang FF; Xu Y; Fu HR; Wang XD; Wang L; Chen W; Xu XY; Gao YF; Zhang JG; Zhang HT
Int J Neuropsychopharmacol; 2020 Dec; 23(10):700-711. PubMed ID: 32645141
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase-4 inhibitors ameliorates cognitive deficits in deoxycorticosterone acetate induced hypertensive rats via cAMP/CREB signaling system.
Jabaris SS; Sumathy H; Girish R; Narayanan S; Sugumar M; Saravana Babu C; Thanikachalam S; Thanikachalam M
Brain Res; 2015 Oct; 1622():279-91. PubMed ID: 26168894
[TBL] [Abstract][Full Text] [Related]
5. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
[TBL] [Abstract][Full Text] [Related]
6. Novel Phenylethanoid Glycosides Improve Hippocampal Synaptic Plasticity via the Cyclic Adenosine Monophosphate-CREB-Brain-Derived Neurotrophic Growth Factor Pathway in APP/PS1 Transgenic Mice.
Ji S; Wu Y; Zhu R; Guo D; Jiang Y; Huang L; Ma X; Yu L
Gerontology; 2023; 69(9):1065-1075. PubMed ID: 37285833
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington's disease through inhibition of NF-κB mediated neuroinflammatory markers and activation of cAMP/CREB/BDNF signaling pathway.
Saroj P; Bansal Y; Singh R; Akhtar A; Sodhi RK; Bishnoi M; Sah SP; Kuhad A
Inflammopharmacology; 2021 Apr; 29(2):499-511. PubMed ID: 33517508
[TBL] [Abstract][Full Text] [Related]
8. Roflumilast and tadalafil improve learning and memory deficits in intracerebroventricular Aβ1-42 rat model of Alzheimer's disease through modulations of hippocampal cAMP/cGMP/BDNF signaling pathway.
Hasan N; Zameer S; Najmi AK; Parvez S; Yar MS; Akhtar M
Pharmacol Rep; 2021 Oct; 73(5):1287-1302. PubMed ID: 33860460
[TBL] [Abstract][Full Text] [Related]
9. 3,6'-Disinapoyl sucrose alleviates cognitive deficits in APP/PS1 transgenic mice.
Yuan J; He M; Dai X; Huo Q; Chang P; Zhang J; Wang S; Sun Y
J Neurophysiol; 2023 Nov; 130(5):1174-1182. PubMed ID: 37702542
[TBL] [Abstract][Full Text] [Related]
10. The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses.
Vanmierlo T; Creemers P; Akkerman S; van Duinen M; Sambeth A; De Vry J; Uz T; Blokland A; Prickaerts J
Behav Brain Res; 2016 Apr; 303():26-33. PubMed ID: 26794595
[TBL] [Abstract][Full Text] [Related]
11. Roflumilast, a Phosphodiesterase-4 Inhibitor, Ameliorates Sleep Deprivation-Induced Cognitive Dysfunction in C57BL/6J Mice.
Bhat A; Bishir M; Pandi-Perumal SR; Chang SL; Chidambaram SB
ACS Chem Neurosci; 2022 Jul; 13(13):1938-1947. PubMed ID: 35736514
[TBL] [Abstract][Full Text] [Related]
12. Roflumilast Reduces Pathological Symptoms of Sporadic Alzheimer's Disease in Rats Produced by Intracerebroventricular Streptozotocin by Inhibiting NF-κB/BACE-1 Mediated Aβ Production in the Hippocampus and Activating the cAMP/BDNF Signalling Pathway.
Hasan N; Zameer S; Najmi AK; Parvez S; Akhtar M
Neurotox Res; 2022 Apr; 40(2):432-448. PubMed ID: 35192144
[TBL] [Abstract][Full Text] [Related]
13. DAla2-GIP-GLU-PAL Protects Against Cognitive Deficits and Pathology in APP/PS1 Mice by Inhibiting Neuroinflammation and Upregulating cAMP/PKA/CREB Signaling Pathways.
Yuan L; Zhang J; Guo JH; Holscher C; Yang JT; Wu MN; Wang ZJ; Cai HY; Han LN; Shi H; Han YF; Qi JS
J Alzheimers Dis; 2021; 80(2):695-713. PubMed ID: 33579843
[TBL] [Abstract][Full Text] [Related]
14. Roflumilast ameliorates cognitive deficits in a mouse model of amyloidogenesis and tauopathy: Involvement of nitric oxide status, Aβ extrusion transporter ABCB1, and reversal by PKA inhibitor H89.
Ashour NH; El-Tanbouly DM; El Sayed NS; Khattab MM
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110366. PubMed ID: 34051306
[TBL] [Abstract][Full Text] [Related]
15. Sub-efficacious doses of phosphodiesterase 4 and 5 inhibitors improve memory in a mouse model of Alzheimer's disease.
Gulisano W; Tropea MR; Arancio O; Palmeri A; Puzzo D
Neuropharmacology; 2018 Aug; 138():151-159. PubMed ID: 29885420
[TBL] [Abstract][Full Text] [Related]
16. Osthole Upregulates BDNF to Enhance Adult Hippocampal Neurogenesis in APP/PS1 Transgenic Mice.
Liu H; Xue X; Shi H; Qi L; Gong D
Biol Pharm Bull; 2015; 38(10):1439-49. PubMed ID: 26424009
[TBL] [Abstract][Full Text] [Related]
17. Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats.
Jabaris SG; Sumathy H; Kumar RS; Narayanan S; Thanikachalam S; Babu CS
Eur J Pharmacol; 2015 Jan; 746():138-47. PubMed ID: 25446433
[TBL] [Abstract][Full Text] [Related]
18. Procyanidins Extracted from the Lotus Seedpod Ameliorate Cognitive Impairment through CREB-BDNF Pathway Mediated LTP in
Wang Z; Li X; Ren X; Zhao S; Chen W; Fan C; Xu Y; Pi X; Zhang Y; Wang T; Rong S
Curr Pharm Biotechnol; 2023; 24(12):1560-1567. PubMed ID: 36757040
[TBL] [Abstract][Full Text] [Related]
19. β-asarone improves learning and memory and reduces Acetyl Cholinesterase and Beta-amyloid 42 levels in APP/PS1 transgenic mice by regulating Beclin-1-dependent autophagy.
Deng M; Huang L; Ning B; Wang N; Zhang Q; Zhu C; Fang Y
Brain Res; 2016 Dec; 1652():188-194. PubMed ID: 27737765
[TBL] [Abstract][Full Text] [Related]
20. Icariin, a phosphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling.
Jin F; Gong QH; Xu YS; Wang LN; Jin H; Li F; Li LS; Ma YM; Shi JS
Int J Neuropsychopharmacol; 2014 Jun; 17(6):871-81. PubMed ID: 24513083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]